![Melissa Orilall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 708 $ al 31/05/2026
Melissa Orilall currently holds the positions of Vice President-Global Financial Operations at Agenus, Inc. since 2017 and Chief Financial Officer at MiNK Therapeutics, Inc. starting in 2026.
Ms. Orilall completed undergraduate studies at York University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 23/04/2026 | 222 ( 0 % ) | 2 708 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AGENUS INC. | Corporate Officer/Principal | 01/01/2017 |
| MINK THERAPEUTICS, INC. | Director Financiero/CFO | 13/03/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
York University
 York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiNK Therapeutics, Inc.
 MiNK Therapeutics, Inc. BiotechnologyHealth Technology Provides bio pharmaceutical services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
